Role of C-erbB2 expression in gallbladder cancer

Indian Journal of Pathology and Microbiology

Volumn 55, Issue 1, 2012, Pages 75-79

  Kumari, Niraj ^a   Kapoor, V K ^a   Krishnani, Narendra ^a   Kumar, Kamlesh ^a   Baitha, Dinesh Kumar ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

C erbB2; dysplasia; gallbladder cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; GALLBLADDER CANCER; GALLSTONE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTOR, ERBB-2; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84860441673     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.94862     Document Type: Article

References (18)

1. Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, et al. Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol 2008;14:70-5. (Pubitemid 351314329)
2. Lazcano-Ponce EC, Miquel JF, Muńoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-64. (Pubitemid 34232782)
3. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76. (Pubitemid 36322307)
4. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer 2006;118:1591-602. (Pubitemid 43376420)
5. Pandey M. Risk factors for gallbladder cancer: A reappraisal. Eur J Cancer Prev 2003;12:15-24. (Pubitemid 36233018)
6. Kapoor VK, McMichael AJ. Gallbladder cancer: An 'Indian' disease. Natl Med J India 2003;16:209-13. (Pubitemid 37304502)
7. Albores-Saavedra J, Henson DE. Tumors of gallbladder and extrahepatic bile ducts. Fascicle 23, Ed. 3. Washington DC: Armed Forces Institute of Pathology; 2000.
8. Nakazawa K, Dobashi Y, Suzuki S, Fujii H, Takeda Y, Ooi A. Amplification and overexpression of C-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers. J Pathol 2005;206:356-65. (Pubitemid 40903200)
9. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y. p53 and C-erbB-2 protein expression in adenocarcinomas and epithelial dysplasia of the gall bladder. J Pathol 1993;170:67-72. (Pubitemid 23130586)
10. Chaube A, Tewari M, Garbyal RS, Singh U, Shukla HS. Preliminary study of p53 and C-erbB-2 expression in gallbladder cancer in Indian patients. BMC Cancer. 2006 10;6:126. Available from: Http://www.biomedcentral.com/1471-2407/6/ 126. [Last accessed on 2010 Sep 14].
11. Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM. Geographic pathology revisited: Development of an atlas of cancer in India. Int J Cancer 2005;116:740-54. (Pubitemid 41102252)
12. Indian Council of Medical Research. National cancer registry programme. Consolidated report of the population based cancer registries 1990-1996. Incidence and Distribution of cancer. New Delhi: Indian Council of Medical Research; 2001. p. 53.
13. Priya TP, Kapoor VK, Krishnani N, Agrawal V, Agarwal S. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gallbladder cancer. Cancer Invest 2009;27:764-73.
14. Kim YW, Huh SH, Park YK, Yoon TY, Lee SM, Hong SH. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas. Oncol Rep 2001;8;1127-32. (Pubitemid 33758182)
15. Reichelt U, Duesedau P, Tsourlakis MC, Tsourlakis MC, Quaas A, Link BC, et al. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol 2007;20:120-9. (Pubitemid 44967957)
16. Marx AH, Tharun L, Muth J, Dancau AM, Simon R, Yekebas E, et al. HER-2 amplification is highly homogenous in gastric cancer. Hum Pathol 2009;40:769-77.
17. Kawamoto T, Krishnamurthy S, Tarco E, Trivedi S, Wistuba II, Li D, et al. HER Receptor Family: Novel Candidate for Targeted Therapy for Gallbladder and Extrahepatic Bile Duct Cancer. Gastrointest Cancer Res 2007;1:221-7.
18. Goldin RD, Roa JC. Gallbladder cancer: A morphological and molecular update. Histopathology 2009;55:218-29.